Sentinel node identification rate and nodal involvement in the EORTC 10981-22023 AMAROS trial.
Straver
Marieke E
ME
Department of Surgical Oncology, The Netherlands Cancer Institute, Amsterdam, The Netherlands. m.straver@nki.nl
Meijnen
Philip
P
van Tienhoven
Geertjan
G
van de Velde
Cornelis J H
CJ
Mansel
Robert E
RE
Bogaerts
Jan
J
Duez
Nicole
N
Cataliotti
Luigi
L
Klinkenbijl
Jean H G
JH
Westenberg
Helen A
HA
van der Mijle
Huub
H
Snoj
Marko
M
Hurkmans
Coen
C
Rutgers
Emiel J T
EJ
D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D001365:Axilla; D001943:Breast Neoplasms / Q000473:pathology* / Q000532:radiotherapy / Q000601:surgery; D018270:Carcinoma, Ductal, Breast / Q000532:radiotherapy / Q000556:secondary* / Q000601:surgery; D018275:Carcinoma, Lobular / Q000532:radiotherapy / Q000556:secondary* / Q000601:surgery; D005260:Female; D006801:Humans; D008197:Lymph Node Excision; D008207:Lymphatic Metastasis; D008875:Middle Aged; D009367:Neoplasm Staging; D021701:Sentinel Lymph Node Biopsy; D015996:Survival Rate; D016896:Treatment Outcome